Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis

Trial Profile

Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Portal hypertension
  • Focus Registrational; Therapeutic Use
  • Acronyms CIRROXABAN
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 26 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top